Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE GUILLEMAN : revenue, balance sheet and financial ratios

PHARMACIE GUILLEMAN is a French company founded 16 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in ARPAJON (91290), this company of category PME shows in 2020 a net income positive of 159 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE GUILLEMAN (SIREN 512430703)
Indicator 2020 2019 2018 2017
Revenue N/C N/C N/C N/C
Net income 158 557 € 123 481 € 112 930 € 114 205 €
EBITDA N/C N/C N/C N/C
Net margin N/C N/C N/C N/C

Revenue and income statement

In 2020, PHARMACIE GUILLEMAN generates positive net income of 159 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2020: 114 k€ -> 159 k€.

Net income (2020) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

158 557 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 183%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 30%. The balance between equity and debt is satisfactory.

Debt ratio (2020) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

182.891%

Financial autonomy (2020) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

30.112%

Solvency indicators evolution
PHARMACIE GUILLEMAN

Sector positioning

Debt ratio
182.89 2020
2018
2019
2020
Q1: 33.22
Med: 96.81
Q3: 238.41
Average -10 pts over 3 years

In 2020, the debt ratio of PHARMACIE GUILLEMAN (182.89) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
30.11% 2020
2018
2019
2020
Q1: 23.59%
Med: 41.65%
Q3: 61.93%
Average +7 pts over 3 years

In 2020, the financial autonomy of PHARMACIE GUILLEMAN (30.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Positioning of PHARMACIE GUILLEMAN in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 180 transactions of similar company sales in 2020, the value of PHARMACIE GUILLEMAN is estimated at 2 240 831 € (range 1 494 155€ - 3 023 487€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2020
180 transactions
1494k€ 2240k€ 3023k€
2 240 831 € Range: 1 494 155€ - 3 023 487€
NAF 5 année 2020

Valuation method used

Net Income Multiple
158 557 € × 14.1x = 2 240 832 €
Range: 1 494 155€ - 3 023 487€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 180 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE GUILLEMAN with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE GUILLEMAN

What is the revenue of PHARMACIE GUILLEMAN ?

The revenue of PHARMACIE GUILLEMAN is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE GUILLEMAN profitable?

Yes, PHARMACIE GUILLEMAN generated a net profit of 159 k€ in 2020.

Where is the headquarters of PHARMACIE GUILLEMAN ?

The headquarters of PHARMACIE GUILLEMAN is located in ARPAJON (91290), in the department Essonne.

Where to find the tax return of PHARMACIE GUILLEMAN ?

The tax return of PHARMACIE GUILLEMAN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE GUILLEMAN operate?

PHARMACIE GUILLEMAN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.